{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:58:53Z","timestamp":1792292333343,"version":"4.4.0"},"reference-count":152,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Microbiol Rev"],"published-print":{"date-parts":[[2022,9,21]]},"abstract":"<jats:p>Convalescent plasma (CP) recurs as a frontline treatment in epidemics because it is available as soon as there are survivors. The COVID-19 pandemic represented the first large-scale opportunity to shed light on the mechanisms of action, safety, and efficacy of CP using modern evidence-based medicine approaches. Studies ranging from observational case series to randomized controlled trials (RCTs) have reported highly variable efficacy results for COVID-19 CP (CCP), resulting in uncertainty.<\/jats:p>","DOI":"10.1128\/cmr.00200-21","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T11:00:45Z","timestamp":1646823645000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":91,"title":["COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes"],"prefix":"10.1128","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8811-195X","authenticated-orcid":true,"given":"Daniele","family":"Focosi","sequence":"first","affiliation":[{"name":"North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Franchini","sequence":"additional","affiliation":[{"name":"Division of Transfusion Medicine, Carlo Poma Hospital, Mantua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liise-anne","family":"Pirofski","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Albert Einstein College of Medicine and Montefiore Medical Center, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Burnouf","sequence":"additional","affiliation":[{"name":"Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan"},{"name":"International Ph.D. Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Paneth","sequence":"additional","affiliation":[{"name":"Department of Epidemiology &amp; Biostatistics and Pediatrics &amp; Human Development, College of Human Medicine, Michigan State University, East Lansing, Michigan, USA"},{"name":"Department of Pediatrics &amp; Human Development, College of Human Medicine, Michigan State University, East Lansing, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Joyner","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9402-9167","authenticated-orcid":true,"given":"Arturo","family":"Casadevall","sequence":"additional","affiliation":[{"name":"Department of Medicine, Johns Hopkins School of Public Health and School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.03372-20"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI138003"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181d44c1e"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2004168117"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.10044"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.261784"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00072-20"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci140200"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2031893"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3939"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI150646"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2031304"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01175-20"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1101\/2021.12.09.21267513"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","unstructured":"Van Rompay KKA Olstad KJ Sammak RL Dutra J Watanabe JK Usachenko JL Immareddy R Roh JW Verma A Lakshmanappa YS Schmidt BA Germanio CD Rizvi N Stone M Simmons G Dumont LJ Allen AM Lockwood S Pollard RE de Assis RR Yee JL Nham PB Ardeshir A Deere JD Patterson J Jain A Felgner PL Iyer SS Hartigan-O\u2019Connor DJ Busch MP Reader JR. 2021. Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity reduces lung inflammation. bioRxiv. 10.1101\/2021.09.01.458520.","DOI":"10.1101\/2021.09.01.458520"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01551-21"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.01397-21"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.04.003"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1101\/2021.05.04.21256627"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2021.103148"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.08.003"},{"key":"e_1_3_2_23_2","volume-title":"Statistical design and analysis plan for sequential parallel-group RCT for COVID-19","author":"Harrell F","year":"2021","unstructured":"Harrell F, Lindsell C. 2021. Statistical design and analysis plan for sequential parallel-group RCT for COVID-19. Vanderbilt University School of Medicine, Nashville, TN. http:\/\/hbiostat.org\/proj\/covid19\/bayesplan.html."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01420-3"},{"key":"e_1_3_2_25_2","unstructured":"WHO. 2020. WHO R & D blueprint: novel coronavirus: COVID19 therapeutic trial synopsis. https:\/\/www.who.int\/blueprint\/priority-diseases\/key-action\/COVID-19_Treatment_Trial_Design_Master_Protocol_synopsis_Final_18022020.pdf?ua=1. Accessed October 1."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30483-7"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.6850"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2103784"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1101\/2021.11.30.21266810"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00545-2"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1101\/2021.12.10.21267485"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1101\/2021.12.13.21267611"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2170"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2021.26.27.2100568"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01724-2021"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.18178"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23469-2"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16208"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.45.2001754"},{"key":"e_1_3_2_40_2","volume-title":"WHO\/BS\/2020.2403: Establishment of the WHO International Standard and Reference Panel for Anti-SARS-CoV-2 Antibody","author":"Mattiuzzo P","year":"2020","unstructured":"Mattiuzzo P, Bentley E, Hassal M, Routley S, Richardson S, Bernasconi V, Kristianse P, Harvala H, Roberts D, Semple M, Turtle L, Openshaw P, Baillie K. 2020. WHO\/BS\/2020.2403: Establishment of the WHO International Standard and Reference Panel for Anti-SARS-CoV-2 Antibody. WHO Expert Committee on Biological Standardization, Geneva, Switzerland."},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa784"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI151788"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00765-21"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2021.02.005"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.600372"},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4049\/jimmunol.35.5.351","article-title":"Photodynamic action of methylene blue on antipneumococcal serum","volume":"35","author":"Ross V","year":"1938","unstructured":"Ross V. 1938. Photodynamic action of methylene blue on antipneumococcal serum. J Immunol 35:351\u2013369.","journal-title":"J Immunol"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.36246"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89444-5"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI152740:152740"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1159\/000514485"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00897-7"},{"key":"e_1_3_2_52_2","doi-asserted-by":"crossref","unstructured":"Bahnan W Wrighton S Sundwall M Bl\u00e4ckberg A Larsson O H\u00f6glund U Khakzad H Godzwon M Walle M Elder E Happonen L Andr\u00e9 O Kumra Ahnlide J Hellmark T Wendel-Hansen V Wallin RP Malmstr\u00f6m J Malmstr\u00f6m L Ohlin M Rasmussen M Nordenfelt P. 14 October 2021. Opsonization by non-neutralizing antibodies can confer protection to SARS-CoV-2 despite Spike-dependent modulation of phagocytosis. bioRxiv. 10.1101\/2021.10.14.464464.","DOI":"10.1101\/2021.10.14.464464"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI152264:2021.05.10.21256192"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25113-5"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2104241118"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13071211"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1101\/2021.08.20.21262328"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1097\/ccm.0000000000005066"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1101\/2020.10.25.20219337"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1101\/2021.06.15.21258542"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003872"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1101\/2020.08.12.20169359"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1136\/jim-2021-002158"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2021.12.023"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.142270:142270"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1088-9"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2020.08.001"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2020.10.008"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1548"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254453"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17272"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1101\/2021.06.02.21258190"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2033700"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28064-7"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12939"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2021.02.008"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.2747"},{"key":"e_1_3_2_79_2","first-page":"Cd013600","article-title":"Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review","volume":"5","author":"Piechotta V","year":"2021","unstructured":"Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. 2021. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev 5:Cd013600.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06829-7"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.06.034"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16434"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.684151"},{"key":"e_1_3_2_84_2","unstructured":"Casadevall A Grossman BJ Henderson JP Joyner MJ Paneth NS Pirofski LA Shoham S 2021. Please reevaluate the data on convalescent plasma for COVID-19. https:\/\/www.medpagetoday.com\/opinion\/second-opinions\/94256?xid=nl_mpt_DHE_2021-08-30&eun=g1783322d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=Daily%20Headlines%20Top%20Cat%20HeC%20%202021-08-30&utm_term=NL_Daily_DHE_dual-gmail-definition. Accessed 31 August 2021."},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3379"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102898"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13663"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11091663"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI155114"},{"key":"e_1_3_2_90_2","unstructured":"Anonymous. 2021. Continuous monitoring of pooled international trials of convalescent plasma for COVID-19 hospitalized patients. https:\/\/med.nyu.edu\/departments-institutes\/population-health\/divisions-sections-centers\/biostatistics\/research\/continuous-monitoring-pooled-international-trials-convalescent-plasma-covid19-hospitalized-patients. Accessed 31 August 2021."},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.47331"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.47375"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13081594"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2021.06.011"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.06.028"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-00789-5"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2710.211538"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.08.033"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100164"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.07.015"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1932475"},{"key":"e_1_3_2_102_2","unstructured":"Anonymous. 2021. CoVIg-19 Plasma Alliance announces topline results from NIH-sponsored clinical trial of investigational COVID-19 hyperimmune globulin medicine. https:\/\/www.takeda.com\/newsroom\/newsreleases\/2021\/covig-19-plasma-alliance-announces-topline-results-from-nih-sponsored-clinical-trial-of-investigational-covid-19-hyperimmune-globulin-medicine\/. Accessed 2 April 2021."},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2033130"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102685"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1080\/20009666.2021.1978154"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.69866"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1111\/vox.13091"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2021.103071"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16525"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.1799"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148832"},{"key":"e_1_3_2_112_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-021-05847-7"},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2803.212299"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197711172972004"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16401"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1111\/vox.13228"},{"key":"e_1_3_2_117_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04005-0"},{"key":"e_1_3_2_118_2","doi-asserted-by":"publisher","DOI":"10.1101\/2021.10.28.21265622"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16772"},{"key":"e_1_3_2_120_2","doi-asserted-by":"publisher","DOI":"10.1101\/2021.12.07.21267432"},{"key":"e_1_3_2_121_2","doi-asserted-by":"crossref","unstructured":"Cao YR Wang J Jian F Xiao T Song W Yisimayi A Huang W Li Q Wang P An R Wang J Wang Y Niu X Yang S Liang H Sun H Li T Yu Y Cui Q Liu S Yang X Du S Zhang Z Hao X Shao F Jin R Wang X Xiao J Wang Y Xie XS. 2021. B.1.1.529 escapes the majority of SARS-CoV-2 neutralizing antibodies of diverse epitopes. bioRxiv. 10.1101\/2021.12.07.470392.","DOI":"10.1101\/2021.12.07.470392"},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.1101\/2021.11.11.21266207"},{"key":"e_1_3_2_123_2","unstructured":"Anonymous. 27 December 2021. U.S. Food and Drug Administration (FDA) clinical memorandum. Re: EUA 26382. Product: COVID-19 convalescent plasma. Available at https:\/\/www.fda.gov\/media\/141477\/download."},{"key":"e_1_3_2_124_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01488-2"},{"key":"e_1_3_2_125_2","doi-asserted-by":"publisher","DOI":"10.1101\/2021.03.28.21254507"},{"key":"e_1_3_2_126_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01471-2021"},{"key":"e_1_3_2_127_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcvp.2021.100016"},{"key":"e_1_3_2_128_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa656"},{"key":"e_1_3_2_129_2","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16555"},{"key":"e_1_3_2_130_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-020-01361-x"},{"key":"e_1_3_2_131_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2020.114025"},{"key":"e_1_3_2_132_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17266"},{"key":"e_1_3_2_133_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2607.200841"},{"key":"e_1_3_2_134_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpmc.108"},{"key":"e_1_3_2_135_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13020247"},{"key":"e_1_3_2_136_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.142362"},{"key":"e_1_3_2_137_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02492-20"},{"key":"e_1_3_2_138_2","doi-asserted-by":"crossref","unstructured":"Wu F and Wang A and Liu Mei and Wang Q and Chen J and Xia Shuai and Ling Y and Zhang Y and Xun J and Lu Lu and Jiang Shibo and Lu Hongzhou and Wen Y and Huang J. 9 April 2020. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. https:\/\/ssrn.com\/abstract=3566211.","DOI":"10.2139\/ssrn.3566211"},{"key":"e_1_3_2_139_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abe6855"},{"key":"e_1_3_2_140_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.06.020"},{"key":"e_1_3_2_141_2","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.259"},{"key":"e_1_3_2_142_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9040806"},{"key":"e_1_3_2_143_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI141206"},{"key":"e_1_3_2_144_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.02.054"},{"key":"e_1_3_2_145_2","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000003962"},{"key":"e_1_3_2_146_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab834:ciab834"},{"key":"e_1_3_2_147_2","first-page":"357","article-title":"The therapeutic potential of convalescent plasma therapy on treating critically-ill COVID-19 patients residing in respiratory care units in hospitals in Baghdad, Iraq","volume":"28","author":"Rasheed AM","year":"2020","unstructured":"Rasheed AM, Fatak DF, Hashim HA, Maulood MF, Kabah KK, Almusawi YA, Abdulamir AS. 2020. The therapeutic potential of convalescent plasma therapy on treating critically-ill COVID-19 patients residing in respiratory care units in hospitals in Baghdad, Iraq. Infez Med. 28:357\u2013366.","journal-title":"Infez Med"},{"key":"e_1_3_2_148_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003415"},{"key":"e_1_3_2_149_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01638-6"},{"key":"e_1_3_2_150_2","unstructured":"Anonymous. 2021. National COVID19 Convalescent Plasma Project. Commentary from the COVID-19 Convalescent Plasma Project (CCPP19) Leadership Group on \u201cEarly convalescent plasma for high-risk outpatients with Covid-19\u201d. https:\/\/ccpp19.org\/news\/review%20of%20NEJM%20US%20outpatient%20CP%20trial%208-23.docx. Accessed 25 August 2021."},{"key":"e_1_3_2_151_2","unstructured":"Anonymous. 2 March 2021. NIH halts trial of COVID-19 convalescent plasma in emergency department patients with mild symptoms. https:\/\/www.nih.gov\/news-events\/news-releases\/nih-halts-trial-covid-19-convalescent-plasma-emergency-department-patients-mild-symptoms."},{"key":"e_1_3_2_152_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-020-04876-0"},{"key":"e_1_3_2_153_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2022.01.016"}],"container-title":["Clinical Microbiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/cmr.00200-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/cmr.00200-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T13:28:34Z","timestamp":1674912514000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/cmr.00200-21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,21]]},"references-count":152,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9,21]]}},"alternative-id":["10.1128\/cmr.00200-21"],"URL":"https:\/\/doi.org\/10.1128\/cmr.00200-21","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.09.07.21263194","asserted-by":"object"}]},"ISSN":["0893-8512","1098-6618"],"issn-type":[{"value":"0893-8512","type":"print"},{"value":"1098-6618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,21]]},"assertion":[{"value":"2022-03-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00200-21"}}